Outcomes after 18 Months of Eliglustat Therapy in Treatment ‐Naïve Adults with Gaucher Disease Type 1: The Phase 3 ENGAGE Trial

This article is protected by copyright. All rights reserved.

Source: American Journal of Hematology - August 1, 2017 Category: Hematology Authors: Pramod K. Mistry, Elena Lukina, Hadhami Ben Turkia, Suma P. Shankar, Hagit Baris, Marwan Ghosn, Atul Mehta, Seymour Packman, Gregory Pastores, Milan Petakov, Sarit Assouline, Manisha Balwani, Sumita Danda, Evgueniy Hadjiev, Andres Ortega, Sebastiaan J.M. Tags: Research Article Source Type: research